Publication Planning 
and Dissemination

Publication planning and execution provides a compliant and coherent means of effectively communicating the scientific, clinical and health economic evidence supporting the value of your scientific activities. It also ensures that this information wins ‘share-of-voice’ and is communicated to appropriate audiences in a timely manner.

Members of the Niche team have a wealth of experience in strategic publication planning and in providing leadership in evolving industry standards and practices. Through a structured and collaborative approach, the team develops and executes evidence-based publication strategies that align with the product’s lifecycle, scientific platform, and communication objectives.

“I worked with Niche on the EU-funded MID-Frail and Frailomic initiatives, involving 20 scientific, academic and commercial organisations. Once again, the Niche team were identified as the partners for delivering the communication platform, building our strategic communications plan and coordinating our dissemination and exploitation activities. Together, we have generated and promoted a host of scientific and tertiary communications detailing our initiatives and findings.”
Prof. Alan Sinclair
Medical and Scientific Coordinator, UK

We help our clients to develop and shape comprehensive solutions to complex strategic challenges. All activities are delivered under a robust quality and compliance framework, ensuring adherence to industry standards such as GPP (Good Publication Practice), ICMJE, and company-specific SOPs.

Our extensive industry experience means we have an in-depth market understanding, which, combined with our expertise in insight-driven scientific and medical communications, enables us to generate imaginative, workable ideas with a focus on scientific integrity, clarity, and impact.

Frequently Asked Questions
We start by working closely with cross-functional teams, including pre-clinical, clinical, regulatory, and commercial stakeholders, to ensure our outline plan aligns with the overall development and commercialisation strategy. 

We map out key clinical milestones, pivotal trial results, and regulatory submissions to identify the best timing for a variety of activities aimed at releasing key messages in specific vehicles across a range of channels to win ‘share-of-voice.’
We conduct a gap analysis to understand what data needs to be communicated, and what may have already been published. We structure the plan to address key stakeholder needs at different stages—physicians, payers, regulators, and patients.

For example, early in development, conference abstracts and posters are crucial for building awareness. As pivotal trial results become available, primary manuscripts in high-impact journals become the focus. Review articles and meta-analyses may follow to provide context for the broader implications of the drug.

Prioritisation is driven by the timing of data availability, the competitive landscape, and the target audience.

Clear, consistent communication and well-defined deliverable milestones/timelines are vital for successful publication planning. We facilitate regular meetings with the internal team, including medical, clinical, and marketing, to ensure everyone is aligned on goals and timelines. We aim to maintain close relationships with authors and KOLs, involving them early in manuscript development and seeking their input at key stages.

We manage timelines rigorously to ensure timely submissions and coordinate across different stakeholders to avoid publication delays. My approach is collaborative and transparent, ensuring that all contributors are informed and engaged throughout the process.

We prioritise high-impact journals and conferences at critical points, such as before major regulatory decisions or market entry. The goal is to ensure that key messages and data are disseminated in a way that supports both scientific and commercial objectives."

Case Histories

Industry news and comment

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility
chevron-down